Literature DB >> 10951229

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

S Bastuji-Garin1, N Fouchard, M Bertocchi, J C Roujeau, J Revuz, P Wolkenstein.   

Abstract

The mortality of toxic epidermal necrolysis is about 30%. Our purpose was to develop and validate a specific severity-of-illness score for cases of toxic epidermal necrolysis admitted to a specialized unit and to compare it with the Simplified Acute Physiology Score and a burn scoring system. A sample of 165 patients was used to develop the toxic epidermal necrolysis-specific severity-of-illness score and evaluate the other scores, a sample of 75 for validation. Model development used logistic regression equations that were translated into probability of hospital mortality; validation used measures of calibration and discrimination. We identified seven independent risk factors for death and constituted the toxic epidermal necrolysis-specific severity-of-illness score: age above 40 y, malignancy, tachycardia above 120 per min, initial percentage of epidermal detachment above 10%, serum urea above 10 mmol per liter, serum glucose above 14 mmol per liter, and bicarbonate below 20 mmol per liter. For each toxic epidermal necrolysis-specific severity-of-illness score point the odds ratio was 3.45 (confidence interval 2.26-5.25). Probability of death was: P(death) = elogit/1 + elogit with logit = -4.448 + 1.237 (toxic epidermal nec-rolysis-specific severity-of-illness score). Calibration demonstrated excellent agreement between expected (19. 6%) and actual (20%) mortality; discrimination was also excellent with a receiver operating characteristic area of 82%. The Simplified Acute Physiology Score and the burn score were also associated with mortality. The discriminatory powers were poorer (receiver operating characteristic area: 72 and 75%) and calibration of the Simplified Acute Physiology Score indicated a poor agreement between expected (9.1%) and actual (26.7%) mortality. This study demonstrates that the risk of death of toxic epidermal necrolysis patients can be accurately predicted by the toxic epidermal necrolysis-specific severity-of-illness score. The Simplified Acute Physiology Score and burn score appear to be less adequate.

Entities:  

Mesh:

Year:  2000        PMID: 10951229     DOI: 10.1046/j.1523-1747.2000.00061.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  169 in total

Review 1.  Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.

Authors:  Olivia A Charlton; Victoria Harris; Kevin Phan; Erin Mewton; Chris Jackson; Alan Cooper
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-09       Impact factor: 4.730

2.  [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].

Authors:  Argyrios Chronopoulos; Maja Mockenhaupt; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-03-16       Impact factor: 1.059

Review 3.  [Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

4.  [Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin].

Authors:  P Spornraft-Ragaller; H Theilen; G S Gottschlich; M Ragaller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

5.  [Toxic epidermal necrolysis].

Authors:  V Lewerenz; D Bruch-Gerharz; T Ruzicka; R Kruse
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

6.  Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Authors:  Chuang-Wei Wang; Lan-Yan Yang; Chun-Bing Chen; Hsin-Chun Ho; Shuen-Iu Hung; Chih-Hsun Yang; Chee-Jen Chang; Shih-Chi Su; Rosaline Chung-Yee Hui; See-Wen Chin; Li-Fang Huang; Yang Yu-Wei Lin; Wei-Yang Chang; Wen-Lang Fan; Chin-Yi Yang; Ji-Chen Ho; Ya-Ching Chang; Chun-Wei Lu; Wen-Hung Chung
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 7.  Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes.

Authors:  Manuel Florian Struck; Peter Hilbert; Maja Mockenhaupt; Beate Reichelt; Michael Steen
Journal:  Intensive Care Med       Date:  2009-09-29       Impact factor: 17.440

8.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Guide for Nurses.

Authors:  Leah M Hanson; Amanda P Bettencourt
Journal:  AACN Adv Crit Care       Date:  2020-09-15

9.  Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database.

Authors:  Susannah M C George; David A Harrison; Catherine A Welch; Kathleen M Nolan; Peter S Friedmann
Journal:  Crit Care       Date:  2008-01-18       Impact factor: 9.097

10.  Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report.

Authors:  Mohamed El Ghonemi; Hesham R Omar; Rania Rashad; Jaya Kolla; Devanand Mangar; Enrico Camporesi
Journal:  Cases J       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.